Advertisement

Archive

2017: Issue 5 2017 (pp. 822-1005)

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

21 articles
1.

See also Serebruany et al.

D. Sibbing (1, 2), D. Aradi (3, 4)

(1) Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig Maximilians-Universität München, Germany; (2) DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany; (3) Department of Cardiology, Heart Center Balatonfüred, Semmelweis University, Budapest, Hungary; (4) Heart and Vascular Center, Semmelweis University, Budapest, Hungary

Thromb Haemost 2017 117 5: 823-825

https://doi.org/10.1160/TH17-03-0180

[Summary] [Free PDF] [Export citation]
2.

See also Asher et al. and Niezgoda et al.

F. Rollini (1), F. Franchi (1), D. J. Angiolillo (1)

(1) University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA

Thromb Haemost 2017 117 5: 826-828

https://doi.org/10.1160/TH17-03-0177

[Summary] [Free PDF] [Export citation]
3.

See also Park et al.

G. M. Podda (1), M. Cattaneo (1)

(1) Unità di Medicina III, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy

Thromb Haemost 2017 117 5: 829-829

https://doi.org/10.1160/TH17-03-0167

[Summary] [Free PDF] [Export citation]
4.
Detection of procoagulant imbalance
Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin

A. Tripodi (1)

(1) Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy and IRCCS Cà Granda Maggiore Hospital Foundation, Milano, Italy

Thromb Haemost 2017 117 5: 830-836

https://doi.org/10.1160/TH16-10-0806

[Summary] [Free PDF] [Export citation]
5.
Open Access
Are cardiovascular risk factors also associated with the incidence of atrial fibrillation?
A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants

Online Supplementary Material

V. Allan (1), S. Honarbakhsh (2), J.-P. Casas (1), J. Wallace (1), R. Hunter (2), R. Schilling (2), P. Perel (3), K. Morley (4), A. Banerjee (1), H. Hemingway (1)

(1) Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, UK; (2) The Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust & Queen Mary, University of London, London, UK; (3) Centre for Global Non Communicable Diseases, London School of Hygiene & Tropical Medicine, London, UK; (4) Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, UK

Thromb Haemost 2017 117 5: 837-850

https://doi.org/10.1160/TH16-11-0825

[Summary] [Free PDF] [Export citation]
6.
Open Access

M. Hayakawa (1), S. Kushimoto (2), E. Watanabe (3), K. Goto (4), Y. Suzuki (5), T. Kotani (6), T. Kiguchi (7), T. Yatabe (8), J. Tagawa (9), F. Komatsu (9), S. Gando (1)

(1) Emergency and Critical Care Center, Hokkaido University Hospital, Hokkaido, Japan; (2) Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Tohoku, Japan; (3) Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan; (4) Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, Oita University, Oita, Japan; (5) Department of Critical Care Medicine, Iwate Medical University, Iwate, Japan; (6) Department of Anesthesiology and Intensive Care Medicine, Tokyo Women’s Medical University, Tokyo, Japan; (7) Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan; (8) Department of Anesthesiology and Intensive Care Medicine, Kochi Medical School, Kochi, Japan; (9) Clinical Development Center, Asahi Kasei Pharma Co., Tokyo, Japan

Thromb Haemost 2017 117 5: 851-859

https://doi.org/10.1160/TH16-07-0547

[Summary] [Free PDF] [Export citation]
7.

T. Iwaki (1), K. Nagahashi (1, 2), K. Takano (3), K. Suzuki-Inoue (3), N. Kanayama (2), K. Umemura (1), T. Urano (4)

(1) Department of Pharmacology, Hamamatsu University School of Medicine, Hamamatsu, Japan; (2) Department of Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan; (3) Department of Clinical and Laboratory Medicine, University of Yamanashi, Yamanashi, Japan; (4) Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan

Thromb Haemost 2017 117 5: 860-869

https://doi.org/10.1160/TH16-07-0572

[Summary] [PDF] [Pay per view] [Export citation]
8.

Online Supplementary Material

E. Hüttel (1), S. Padberg (1), R. Meister (2), E. Beck (1), C. Schaefer (1)

(1) Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charité - Universitätsmedizin Berlin, Germany; (2) Department of Mathematics, Beuth Hochschule für Technik Berlin (University of Applied Sciences), Berlin, Germany

Thromb Haemost 2017 117 5: 870-879

https://doi.org/10.1160/TH16-11-0838

[Summary] [PDF] [Pay per view] [Export citation]
9.

M. de la Morena-Barrio (1, 2), E. Sandoval (3), P. Llamas (4), E. Wypasek (5, 6), M. Toderici (1), J. Navarro-Fernández (1), A. Rodríguez-Alen (3), N. Revilla (1), R. López-Gálvez (1), A. Miñano (1), J. Padilla (1), B. de la Morena-Barrio (1), J. Cuesta (3), J. Corral (1, 2), V. Vicente (1, 2)

(1) Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain; (2) Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; (3) Servicio de Hematología y Hemoterapia, Hospital Virgen de la Salud, Toledo, Spain; (4) Servicio de Hematología y Hemoterapia, Fundación Jiménez Díaz, Murcia, Spain; (5) The John Paul II Hospital, Kraków, Poland; (6) Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland

Thromb Haemost 2017 117 5: 880-888

https://doi.org/10.1160/TH16-11-0866

[Summary] [PDF] [Pay per view] [Export citation]
10.

Online Supplementary Material

M. J. R. Desborough (1, 2), K. S. Colman (3), B. W. Prick (4), J. J. Duvekot (4), C. Sweeney (5), A. Odutayo (6), V. Jairath (7, 8), C. Doree (9), M. Trivella (6), S. Hopewell (10), L. J. Estcourt (1, 2), S. J. Stanworth (1, 2)

(1) NHS Blood and Transplant, Oxford, UK; (2) Oxford Clinical Research in Transfusion Medicine, University of Oxford, UK; (3) Monash University Medical School, Melbourne, Victoria, Australia; (4) Department of Obstetrics and Gynaecology, Erasmus Medical Centre, Rotterdam, the Netherlands; (5) Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; (6) Centre for Statistics in Medicine, University of Oxford, UK; (7) Departments of Medicine, Epidemiology and Biostatistics, Western University, London, Ontario, Canada; (8) Nuffield Department of Medicine, University of Oxford, Oxford, UK; (9) Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK; (10) Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, University of Oxford, UK

Thromb Haemost 2017 117 5: 889-898

https://doi.org/10.1160/TH17-01-0015

[Summary] [PDF] [Pay per view] [Export citation]
11.
Open Access

V. Binder (1), B. Bergum (1), S. Jaisson (2), P. Gillery (2), C. Scavenius (3), E. Spriet (4), A. K. Nyhaug (4), H. M. Roberts (5), I. L. C. Chapple (5), A. Hellvard (6), N. Delaleu (1, 7), P. Mydel (1, 8)

(1) Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway; (2) University of Reims Champagne-Ardenne, Laboratory of Biochemistry and Molecular Biology, CNRS/URCA UMR N° 7369 MEDyC, Reims, France; (3) Interdisciplinary Nanoscience Center at the Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark; (4) Department of Biomedicine, University of Bergen, Bergen, Norway; (5) Periodontal Research Group MRC Centre for Immune Regulation, University of Birmingham, Birmingham, UK; (6) Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland; (7) Swiss Institute of Bioinformatics, Lausanne, Switzerland; (8) Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland

Thromb Haemost 2017 117 5: 899-910

https://doi.org/10.1160/TH16-09-0704

[Summary] [Free PDF] [Export citation]
12.

See also Podda, Cattaneo

Y. Park (1), U. S. Tantry (2), J.-S. Koh (3), J.-H. Ahn (1), M. G. Kang (3), K. H. Kim (3), J. Y. Jang (1), H. W. Park (3), J.-R. Park (3), S.-J. Hwang (3), K.-S. Park (4), C. H. Kwak (1), J.-Y. Hwang (3), P. A. Gurbel (2), Y.-H. Jeong (1, 5)

(1) Department of Internal Medicine, Gyeongsang National University School of Medicine and Cardiovascular Center, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea; (2) Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, Virginia, USA; (3) Department of Internal Medicine, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Republic of Korea; (4) Department of Preventive Medicine, Gyeongsang National University School of Medicine, Jinju, Republic of Korea; (5) Institute of the Health Sciences, Gyeongsang National University, Jinju, Republic of Korea

Thromb Haemost 2017 117 5: 911-922

https://doi.org/10.1160/TH16-10-0744

[Summary] [PDF] [Pay per view] [Export citation]
13.
Open Access

M. K. Freynhofer (1), L. Iliev (1), V. Bruno (1, 2), M. Rohla (1), F. Egger (1), T. W. Weiss (1, 3), W. Hübl (4), M. Willheim (4), J. Wojta (5, 6), K. Huber (1, 3)

(1) 3rd Medical Department, Cardiology, Wilhelminenhospital, Vienna, Austria; (2) Department of Obstetrics and Gynecology, Wilhelminenhospital, Vienna, Austria; (3) Medical Faculty, Sigmund Freud University, Vienna, Austria; (4) Department of Laboratory Medicine, Wilhelminenhospital, Vienna, Austria; (5) Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria; (6) Department of Cardiology, Medical University of Vienna, Vienna, Austria

Thromb Haemost 2017 117 5: 923-933

https://doi.org/10.1160/TH16-10-0785

[Summary] [Free PDF] [Export citation]
14.
Mortality and cancer after 12 versus 30 months dual antiplatelet therapy
The Korean Outcomes Registry Evaluating Antithrombotics (KOREA)

See also Sibbing, Aradi

V. L. Serebruany (1), M. H. Kim (2), H. A. Cabrera-Fuentes (3, 4, 5, 6), K. Lee (2), Y. R. Cho (2), K. Park (2), T. H. Park (2), Y. D. Kim (2), S.-C. Yoon (7)

(1) HeartDrug™ Research Laboratories, Johns Hopkins University, Towson, Maryland, USA; (2) Department of Cardiology, College of Medicine, Dong-A University, Busan, Republic of Korea; (3) Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore; (4) Institute of Biochemistry, Medical School, Justus-Liebig-University, Giessen, Germany; (5) National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore; (6) Kazan Federal University, Department of Microbiology, Kazan, Russian Federation; (7) Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Seoul, Republic of Korea

Thromb Haemost 2017 117 5: 934-939

https://doi.org/10.1160/TH16-12-0971

[Summary] [PDF] [Pay per view] [Export citation]
15.

Online Supplementary Material

M. R. Thomas (1), D. J. Angiolillo (2), M. P. Bonaca (3), R. A. Ajjan (4), H. M. Judge (1), F. Rollini (2), F. Franchi (2), A. J. Ahsan (5), D. L. Bhatt (3), J. F. Kuder (3), P. G. Steg (6), M. Cohen (7), R. Muthusamy (8), M. S. Sabatine (3), R. F. Storey (1)

(1) Cardiovascular Research Unit, Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; (2) Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA; (3) TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA; (4) Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK; (5) Trent Cardiac Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK; (6) INSERM-Unité 1148, Assistance Publique- Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, and Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; (7) Newark Beth Israel Medical Center, Rutgers–New Jersey Medical School, Newark, New Jersey, USA; (8) Rotherham NHS Foundation Trust, Rotherham, UK

Thromb Haemost 2017 117 5: 940-947

https://doi.org/10.1160/TH16-09-0703

[Summary] [PDF] [Pay per view] [Export citation]
16.

Online Supplementary Material

L. Clancy (1), L. M. Beaulieu (1), K. Tanriverdi (1), J. E. Freedman (1)

(1) University of Massachusetts Medical School, Department of Medicine, Division of Cardiovascular Medicine, Worcester, Massachusetts, USA

Thromb Haemost 2017 117 5: 948-961

https://doi.org/10.1160/TH16-11-0873

[Summary] [PDF] [Pay per view] [Export citation]
17.

X. Kong (1), L. M. Simon (2), M. Holinstat (3), C. A. Shaw (2, 4), P. F. Bray (1), L. C. Edelstein (1)

(1) The Cardeza Foundation for Hematologic Research and the Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; (2) Department of Structural and Computational Biology and Molecular Biophysics, Baylor College of Medicine, Houston, Texas, USA; (3) Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, USA; (4) Department of Statistics, Rice University, Houston, Texas, USA

Thromb Haemost 2017 117 5: 962-970

https://doi.org/10.1160/TH16-09-0692

[Summary] [PDF] [Pay per view] [Export citation]
18.

Online Supplementary Material

K. Urbanski (1), D. Ludew (1), G. Filip (2), M. Filip (1), A. Sagan (1, 3), P. Szczepaniak (1), G. Grudzien (2), J. Sadowski (2), B. Jasiewicz-Honkisz (1), T. Sliwa (1), B. Kapelak (2), E. McGinnigle (3), T. Mikolajczyk (1, 3), T. J. Guzik (1, 3)

(1) Translational Medicine Laboratory, Department of Internal Medicine, Jagiellonian University, Collegium Medicum, Krakow, Poland; (2) Department of Cardiovascular Surgery and Transplantation, Institute of Cardiology, Jagiellonian University Collegium Medicum, Krakow, Poland; (3) British Heart Foundation Centre for Excellence, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, UK

Thromb Haemost 2017 117 5: 971-980

https://doi.org/10.1160/TH16-08-0614

[Summary] [PDF] [Pay per view] [Export citation]
19.

Online Supplementary Material

B. Reynés (1, 2), E. M. van Schothorst (3), E. García-Ruiz (1, 2), J. Keijer (3), A. Palou (1, 2), P. Oliver (1, 2)

(1) Laboratory of Molecular Biology, Nutrition and Biotechnology, Universitat de les Illes Balears, Palma de Mallorca, Spain; (2) CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), Palma de Mallorca, Spain; (3) Human and Animal Physiology, Wageningen University, Wageningen, the Netherlands

Thromb Haemost 2017 117 5: 981-991

https://doi.org/10.1160/TH16-12-0931

[Summary] [PDF] [Pay per view] [Export citation]
20.

Online Supplementary Material

J. Wu (1), C. Fan (1), L. Ma (1), T. Liu (1), C. Wang (1), J. Song (1), Q. Lv (2), H. Pan (3), C. Zhang (1), J. Wang (1)

(1) Department of Clinical Laboratory, Jinling Hospital, Medical School of Nanjing University, Nanjing, China; (2) Department of Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China; (3) Department of Neurosurgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China

Thromb Haemost 2017 117 5: 992-1001

https://doi.org/10.1160/TH16-08-0606

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-21